Rising Prostate Cancer Cases: Expert Warnings
- Despite being the second most common cancer among men in Europe, prostate cancer remains underdiscussed in Greece, with increasing incidence rates and a critical need for improved data...
- Prostate cancer represents a substantial global health challenge.
- Experts estimate that over 7,000 new cases of prostate cancer are diagnosed in Greece each year, meaning roughly 19 Greek men learn they have the disease daily.Despite these...
“`html
Rising Prostate Cancer Rates in Greece Demand Increased Awareness and Screening
Table of Contents
Despite being the second most common cancer among men in Europe, prostate cancer remains underdiscussed in Greece, with increasing incidence rates and a critical need for improved data collection and screening programs.
The Growing Burden of Prostate Cancer
Prostate cancer represents a substantial global health challenge. Worldwide, it is the fifth leading cause of cancer-related deaths among men, accounting for approximately 375,000 deaths and 1.5 million new cases annually. In Europe, it is the second most common cancer diagnosed in men. greece, however, faces a particular challenge with underdiagnosis and a lack of comprehensive data.
Experts estimate that over 7,000 new cases of prostate cancer are diagnosed in Greece each year, meaning roughly 19 Greek men learn they have the disease daily.Despite these significant numbers, a major obstacle to effective intervention is the absence of a reliable national cancer registry. “Unluckily, we lack reliable national data,” stated oncologist Christos Christodoulou, emphasizing the urgent need for improved surveillance.
Shifting Incidence Trends: A Global and Greek Outlook
While global trends initially showed a decline in prostate cancer incidence, recent data indicates a concerning reversal. The American Cancer Society reports a 6.4% annual decrease in incidence between 2007 and 2014.However, since 2015, rates have been increasing at a rate of 3% per year.More alarmingly, diagnoses of advanced-stage prostate cancer have risen by nearly 5% during the same period.
Several factors contribute to this shift. The aging male population is a primary driver, as the risk of prostate cancer increases with age. However, a significant contributing factor is the lack of routine screening. Early detection is paramount, but many men do not undergo regular prostate checks.
The Challenge of Early Detection
Diagnosing prostate cancer in its early stages can be difficult. “Symptoms at early stages resemble benign prostate hyperplasia, so delays in diagnosis are common,” explained Ploutarchos Anezinis, a urologist at the University of Crete. This similarity in symptoms often leads to misdiagnosis or delayed medical attention.
Dr. Anezinis recommends that men begin regular prostate checks at age 50, including Prostate-Specific Antigen (PSA) blood tests and physical exams. For men with a family history of prostate cancer, he advises starting these checks at age 45.
PSA Testing: Controversy and Importance
PSA testing remains a subject of debate due to the potential for false positive and false negative results.A false positive can lead to unneeded anxiety and invasive procedures (biopsies), while a false negative can delay diagnosis and treatment. Despite these concerns, experts emphasize that PSA testing remains a valuable tool in guiding further investigation.
“PSA is the best tumor marker we have today,” stated Dr.Anezinis. It helps clinicians determine when to recommend imaging studies, such as MRI, and biopsies to confirm or rule out the presence of cancer. The key is to interpret PSA levels in conjunction with other factors, including age, family history, and physical exam findings.
Understanding Prostate Cancer: Key Terms and Concepts
| term | Definition |
|---|---|
| Prostate | A small gland in men that produces fluid for semen. |
| PSA (Prostate-specific Antigen) | A protein produced by the prostate gland; elevated levels can indicate prostate cancer, but also other conditions. |